Gentex Corporation [NASDAQ: GNTX] gained 0.18% or 0.05 points to close at $27.23 with a heavy trading volume of 1181226 shares. The company report on October 5, 2020 that RetiSpec Announces Partnership With Gentex To Commercialize Alzheimer’s Disease Detection Technology.
RetiSpec Inc. announced today that it is partnering with Gentex Corporation (NASDAQ: GNTX) to engineer, manufacture and commercialize technology for the early detection of Alzheimer’s disease.
RetiSpec is an artificial intelligence (AI) medical imaging company developing tools for the early detection of disease biomarkers in the eye. Gentex develops, engineers and manufactures electro-optical products for a wide variety of industries, including automotive, aerospace, fire protection and medical.
It opened the trading session at $27.28, the shares rose to $27.40 and dropped to $27.05, the range by which the price of stock traded the whole day. The daily chart for GNTX points out that the company has recorded 13.93% gains over the past six months. However, it is still -39.78% lower than its most recent low trading price.
If we look at the average trading volume of 1.61M shares, GNTX reached to a volume of 1181226 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Gentex Corporation [GNTX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GNTX shares is $28.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GNTX stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
KeyBanc Capital Markets have made an estimate for Gentex Corporation shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 27, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on June 30, 2020, representing the official price target for Gentex Corporation stock. Previously, the target price had yet another raise from $27 to $32, while Robert W. Baird kept a Outperform rating on GNTX stock.
The Average True Range (ATR) for Gentex Corporation is set at 0.65, with the Price to Sales ratio for GNTX stock in the period of the last 12 months amounting to 4.17. The Price to Book ratio for the last quarter was 3.61, with the Price to Cash per share for the same quarter was set at 1.68. Price to Free Cash Flow for GNTX in the course of the last twelve months was 22.30 with Quick ratio for the last quarter at 2.80.
Trading performance analysis for GNTX stock
Gentex Corporation [GNTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.57. With this latest performance, GNTX shares gained by 1.99% in over the last four-week period, additionally plugging by 13.93% over the last 6 months – not to mention a rise of 5.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GNTX stock in for the last two-week period is set at 60.77, with the RSI for the last a single of trading hit 70.25, and the three-weeks RSI is set at 57.04 for Gentex Corporation [GNTX]. The present Moving Average for the last 50 days of trading for this stock 26.80, while it was recorded at 26.71 for the last single week of trading, and 26.53 for the last 200 days.
Gentex Corporation [GNTX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Gentex Corporation [GNTX] shares currently have an operating margin of +26.28 and a Gross Margin at +37.03. Gentex Corporation’s Net Margin is presently recorded at +22.58.
Return on Total Capital for GNTX is now 25.71, given the latest momentum, and Return on Invested Capital for the company is 22.09. Return on Equity for this stock inclined to 22.09, with Return on Assets sitting at 19.59.
Reflecting on the efficiency of the workforce at the company, Gentex Corporation [GNTX] managed to generate an average of $71,443 per employee. Receivables Turnover for the company is 8.28 with a Total Asset Turnover recorded at a value of 0.87.Gentex Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.80 and a Current Ratio set at 3.90.
Gentex Corporation [GNTX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Gentex Corporation posted 0.44/share EPS, while the average EPS was predicted by analysts to be reported at 0.42/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 4.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GNTX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Gentex Corporation go to 15.00%.
An analysis of insider ownership at Gentex Corporation [GNTX]
There are presently around $5,574 million, or 85.90% of GNTX stock, in the hands of institutional investors. The top three institutional holders of GNTX stocks are: VANGUARD GROUP INC with ownership of 24,090,711, which is approximately -5.268% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 22,779,880 shares of the stock with an approximate value of $620.3 million in GNTX stocks shares; and STATE STREET CORP, currently with $169.43 million in GNTX stock with ownership of nearly -4.252% of the company’s market capitalization.
Positions in Gentex Corporation stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 225 institutional holders increased their position in Gentex Corporation [NASDAQ:GNTX] by around 17,223,319 shares. Additionally, 231 investors decreased positions by around 16,879,723 shares, while 63 investors held positions by with 170,599,600 shares. The mentioned changes placed institutional holdings at 204,702,642 shares, according to the latest SEC report filing. GNTX stock had 59 new institutional investments in for a total of 3,225,544 shares, while 49 institutional investors sold positions of 3,325,486 shares during the same period.